AEON BIOPHARMA INC (AEON)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.24-5.46%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · AEON
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 12.7 | 12.2 | 13.6 | — | 13.7 | — | — |
| R&D Expenses | 7.2 | 4.1 | 14.2 | — | 34.8 | — | — |
| Operating Income | (19.9) | (12.8) | 73.0 | — | (48.4) | (1.9) | — |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | — | — | — | — | 3.7 | 0.1 | — |
| Other Non-Operating Income / Expenses | (34.8) | (26.4) | (31.0) | — | (4.1) | 10.1 | — |
| EBT, Incl. Unusual Items | (54.6) | (39.2) | 42.0 | — | (52.6) | 8.2 | — |
| Income Tax Expense | — | — | — | — | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (54.6) | (39.2) | 42.0 | — | (52.6) | 8.2 | — |
| Per Share | |||||||
| Basic EPS | (1.08) | (3.95) | 77.74 | — | (0.38) | — | — |
| Diluted EPS | (1.08) | (3.95) | 72.93 | — | (0.38) | — | — |
| Basic Weighted Avg Shares | 50.5 | 9.9 | 0.5 | — | 138.8 | — | — |
| Diluted Weighted Avg Shares | 50.5 | 9.9 | 0.6 | — | 138.8 | — | — |
| Supplemental | |||||||
| EBITDA | — | (12.7) | 73.1 | — | (48.4) | — | — |
| EBIT | (19.9) | (12.8) | 73.0 | — | (48.4) | (1.9) | — |
| Effective Tax Rate | — | — | — | — | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.